| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.8M | -9.1% |
| SG&A Expense | $6.7M | +56.0% |
| Operating Income | -$12.6M | -12.0% |
| Interest Expense | -$110K | -18.3% |
| Net Income | -$12.5M | -15.9% |
| EPS (Basic) | -$2.93 | -2.4% |
| EPS (Diluted) | -$2.93 | -2.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | +191.9% |
| Current Assets | $13.8M | +177.6% |
| Total Assets | $14.2M | +148.9% |
| Current Liabilities | $13.0M | +87.2% |
| Stockholders' Equity | -$14.2M | +27.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.9M | +38.0% |
| Financing Cash Flow | $14.7M | +36.1% |